• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

仅在剖腹手术时才发现的、与可手术切除的结直肠癌肝转移相关的未被怀疑且可治疗的转移性疾病的发生率(在进行经皮射频消融时未治疗)。

Incidence of unsuspected and treatable metastatic disease associated with operable colorectal liver metastases discovered only at laparotomy (and not treated when performing percutaneous radiofrequency ablation).

作者信息

Elias D, Sideris L, Pocard M, de Baere T, Dromain C, Lassau N, Lasser P

机构信息

Department of Surgical Oncology, Institut Gustave Roussy, Cancer Center, 39 Rue Camille Desmoulins, 94805, Villejuif Cedex, France.

出版信息

Ann Surg Oncol. 2005 Apr;12(4):298-302. doi: 10.1245/ASO.2005.03.020. Epub 2005 Mar 14.

DOI:10.1245/ASO.2005.03.020
PMID:15827682
Abstract

BACKGROUND

When patients with resectable colorectal liver metastases (LM) are treated with percutaneous radiofrequency (RF), some unsuspected intrahepatic and extrahepatic metastases, detectable only at laparotomy, might be ignored and left untreated. This would result in a reduced cure rate. Our purpose was to discover the incidence of unsuspected and surgically treatable intrahepatic and extrahepatic metastases discovered at laparotomy.

METHODS

The data of 506 patients who underwent a laparotomy and then a hepatectomy for colorectal LM were prospectively collected and retrospectively analyzed. All patients had undergone at least two types of preoperative liver imaging (but no fluorodeoxyglucose-positron emission tomography).

RESULTS

Unsuspected metastases were discovered at laparotomy in 209 patients (41.3%). There were extrahepatic metastases in 82 patients (16.2%), additional LM in 152 patients (30%), and both in 25 patients (4.9%). Liver palpation and intraoperative ultrasound allowed for detecting additional LM in 125 (24.7%) and 48 (9.4%) patients, respectively. All of them were resected. When only the 124 patients who presented with 1 to 3 LM measuring <3 cm in diameter (candidates for percutaneous RF) were considered, the results were similar. Moreover, the incidence of unsuspected metastases was similar when the periods of surgery (before and after January 1996) were considered.

CONCLUSIONS

Laparotomy permits discovery of and treatment with a curative intent of unsuspected intrahepatic or extrahepatic metastases in at least one third of patients with classically resectable colorectal LM. This does not support the use of percutaneous RF ablation instead of hepatic resection for this population, because it will result in an important survival decrease.

摘要

背景

当可切除的结直肠癌肝转移(LM)患者接受经皮射频(RF)治疗时,一些仅在开腹手术时才能检测到的未被怀疑的肝内和肝外转移可能会被忽视而未得到治疗。这将导致治愈率降低。我们的目的是发现开腹手术时发现的未被怀疑且可手术治疗的肝内和肝外转移的发生率。

方法

前瞻性收集并回顾性分析了506例行开腹手术然后肝切除术治疗结直肠癌肝转移患者的数据。所有患者均接受了至少两种类型的术前肝脏影像学检查(但未进行氟脱氧葡萄糖-正电子发射断层扫描)。

结果

209例患者(41.3%)在开腹手术时发现了未被怀疑的转移。其中82例患者(16.2%)有肝外转移,152例患者(30%)有额外的肝转移,25例患者(4.9%)两者皆有。肝脏触诊和术中超声分别在125例(24.7%)和48例(9.4%)患者中检测到额外的肝转移。所有这些转移灶均被切除。当仅考虑124例直径<3 cm的1至3个肝转移灶的患者(适合经皮射频治疗)时,结果相似。此外,考虑手术时期(1996年1月前后)时,未被怀疑转移的发生率相似。

结论

开腹手术能够发现并以治愈为目的治疗至少三分之一经典可切除的结直肠癌肝转移患者中未被怀疑的肝内或肝外转移。这并不支持对该人群使用经皮射频消融术替代肝切除术,因为这将导致生存率显著下降。

相似文献

1
Incidence of unsuspected and treatable metastatic disease associated with operable colorectal liver metastases discovered only at laparotomy (and not treated when performing percutaneous radiofrequency ablation).仅在剖腹手术时才发现的、与可手术切除的结直肠癌肝转移相关的未被怀疑且可治疗的转移性疾病的发生率(在进行经皮射频消融时未治疗)。
Ann Surg Oncol. 2005 Apr;12(4):298-302. doi: 10.1245/ASO.2005.03.020. Epub 2005 Mar 14.
2
Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach".对潜在可切除的肝转移瘤患者进行经皮射频消融:“时间验证法”
Cancer. 2003 Jun 15;97(12):3027-35. doi: 10.1002/cncr.11426.
3
Simultaneous percutaneous right portal vein embolization and left liver tumor radiofrequency ablation prior to a major right hepatic resection for bilateral colorectal metastases.在进行右侧肝脏大部切除以治疗双侧结直肠癌转移之前,同时进行经皮右门静脉栓塞和左肝肿瘤射频消融。
Hepatogastroenterology. 2004 Nov-Dec;51(60):1788-91.
4
Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy.经皮射频热消融术作为肝切除术后肝肿瘤复发治疗的手术替代方案。
Br J Surg. 2002 Jun;89(6):752-6. doi: 10.1046/j.1365-2168.2002.02081.x.
5
Hepatectomy plus intraoperative radiofrequency ablation and chemotherapy to treat technically unresectable multiple colorectal liver metastases.肝切除术联合术中射频消融及化疗治疗技术上不可切除的多发结直肠癌肝转移
J Surg Oncol. 2005 Apr 1;90(1):36-42. doi: 10.1002/jso.20237.
6
The trans-metastasis hepatectomy (through metastases previously ablated with radiofrequency): results of a 13-case study of colorectal cancer.经转移灶射频消融后的肝转移瘤切除术:一项13例结直肠癌病例研究的结果
J Surg Oncol. 2006 Jan 1;93(1):8-12. doi: 10.1002/jso.20391.
7
[Radiofrequency ablation of colorectal liver metastases].[结直肠肝转移瘤的射频消融术]
Tidsskr Nor Laegeforen. 2008 Jan 3;128(1):57-60.
8
[Diagnosis and treatment of colorectal liver metastases - workflow].[结直肠癌肝转移的诊断与治疗——工作流程]
Zentralbl Chir. 2008 Jun;133(3):267-84. doi: 10.1055/s-2008-1076796.
9
Comparison between local ablative therapy and chemotherapy for non-resectable colorectal liver metastases: a prospective study.不可切除的结直肠癌肝转移患者局部消融治疗与化疗的比较:一项前瞻性研究。
Ann Surg Oncol. 2007 Mar;14(3):1161-9. doi: 10.1245/s10434-006-9312-5. Epub 2006 Dec 31.
10
Colorectal liver metastases: recurrence and survival following hepatic resection, radiofrequency ablation, and combined resection-radiofrequency ablation.结直肠癌肝转移:肝切除、射频消融以及联合肝切除-射频消融后的复发与生存情况
Arch Surg. 2008 Dec;143(12):1204-12. doi: 10.1001/archsurg.143.12.1204.

引用本文的文献

1
Fully laparoscopic thermo-ablation of liver malignancies with or without liver resection: tumor location is an independent local recurrence risk factor.完全腹腔镜下肝恶性肿瘤的热消融治疗联合或不联合肝切除术:肿瘤位置是局部复发的独立危险因素。
Surg Endosc. 2021 Feb;35(2):845-853. doi: 10.1007/s00464-020-07456-0. Epub 2020 Feb 19.
2
Exploration of Dynamic Elastic Modulus Changes on Glioblastoma Cell Populations with Aberrant EGFR Expression as a Potential Therapeutic Intervention Using a Tunable Hyaluronic Acid Hydrogel Platform.使用可调节透明质酸水凝胶平台探索具有异常表皮生长因子受体(EGFR)表达的胶质母细胞瘤细胞群体的动态弹性模量变化作为一种潜在的治疗干预措施。
Gels. 2017 Jul 13;3(3):28. doi: 10.3390/gels3030028.
3
Radiofrequency ablation versus resection for technically resectable colorectal liver metastasis: a propensity score analysis.
射频消融与切除术治疗技术上可切除的结直肠癌肝转移:倾向评分分析。
World J Surg Oncol. 2018 Oct 15;16(1):207. doi: 10.1186/s12957-018-1494-3.
4
Intraoperative Ultrasound as a Screening Modality for the Detection of Liver Metastases during Resection of Primary Colorectal Cancer - A Systematic Review.术中超声作为原发性结直肠癌切除术中检测肝转移的筛查方式——一项系统评价
Ultrasound Int Open. 2017 Apr;3(2):E60-E68. doi: 10.1055/s-0043-100503. Epub 2017 Jun 7.
5
Magnetic resonance elastography (MRE) in cancer: Technique, analysis, and applications.癌症中的磁共振弹性成像(MRE):技术、分析及应用
Prog Nucl Magn Reson Spectrosc. 2015 Nov;90-91:32-48. doi: 10.1016/j.pnmrs.2015.06.001. Epub 2015 Jun 23.
6
Regional hepatic therapies: an important component in the management of colorectal cancer liver metastases.区域性肝脏治疗:结直肠癌肝转移管理中的一个重要组成部分。
Hepatobiliary Surg Nutr. 2013 Apr;2(2):97-107. doi: 10.3978/j.issn.2304-3881.2012.12.07.
7
Normal values in healthy liver in central India by acoustic radiation force impulse imaging.印度中部健康肝脏通过声辐射力脉冲成像的正常数值。
J Clin Diagn Res. 2013 Nov;7(11):2498-501. doi: 10.7860/JCDR/2013/7479.3589. Epub 2013 Nov 10.
8
Radiofrequency ablation or resection for small colorectal liver metastases - a plea for caution.小的结直肠癌肝转移灶的射频消融或切除——呼吁谨慎行事。
Quant Imaging Med Surg. 2013 Apr;3(2):63-6. doi: 10.3978/j.issn.2223-4292.2013.04.01.
9
Outcome in disappearing colorectal cancer liver metastases during oxaliplatin-based chemotherapy.基于奥沙利铂化疗期间结直肠癌肝转移灶消失的结局
Oncol Lett. 2012 Nov;4(5):905-909. doi: 10.3892/ol.2012.842. Epub 2012 Aug 3.
10
Thermal tumor ablation therapy for colorectal cancer hepatic metastasis.结直肠癌肝转移的热肿瘤消融治疗。
J Gastrointest Oncol. 2012 Mar;3(1):69-77. doi: 10.3978/j.issn.2078-6891.2012.008.